Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110632922> ?p ?o ?g. }
- W2110632922 endingPage "659" @default.
- W2110632922 startingPage "650" @default.
- W2110632922 abstract "AimTo assess the expression level of fms-like tyrosine kinase 3 (FLT3), the incidence of FLT3/internal tandem duplications (ITD) mutation, and prognostic value of FLT3 changes in different types of adult leukemia.MethodsBone marrow mononuclear cells were isolated from 147 adult patients with leukemia. Reverse transcriptase polymerase chain reaction (PCR) was used to screen FLT3/ITD mutation and quantitative PCR was performed to evaluate the expression of the FLT3 transcript. Flow cytometry was used for detection of FLT3 receptor protein expression on bone marrow mononuclear cells. Pearson correlation analysis was performed to estimate the significance of FLT3.ResultsFLT3 expression was higher in acute myeloid leukemia and B-acute lymphoid leukemia than in T-acute lymphoid leukemia (P = 0.006, P = 0.001) and chronic myelogenous leukemia (P < 0.001). In chronic myelogenous leukemia, FLT3 expression in blast transformation phase was higher than in acceleration phase (P = 0.023). Surface expression of FLT3 protein was correlated with high percentage of bone marrow blasts and with FLT3 mRNA expression (r = 0.366, P < 0.001) in acute leukemia. FLT3/ITDs in the juxtamembrane domain were found in 25% of patients with acute myeloid leukemia and 7% of patients with acute lymphoid leukemia. FLT3/ITD positive sequences had 36, 42, and 57 nucleotides. FLT3/ITD mutation was associated with a higher white blood cell count, higher marrow blast percentage, and elevated serum lactate dehydrogenase (P = 0.045, P = 0.014, P < 0.001, respectively) and not associated with a higher FLT3 mRNA and FLT3 protein expression, and lower complete remission (P = 0.091, P = 0.060, P = 0.270, respectively).ConclusionFLT3 expression levels differed in different types of adult leukemia. Overexpression of FLT3 and presence of a positive FLT3/ITD mutation in acute leukemia were associated with unfavorable clinical characteristics and poor prognosis." @default.
- W2110632922 created "2016-06-24" @default.
- W2110632922 creator A5015269135 @default.
- W2110632922 creator A5022802322 @default.
- W2110632922 creator A5036131563 @default.
- W2110632922 creator A5042754123 @default.
- W2110632922 creator A5050440341 @default.
- W2110632922 creator A5052843372 @default.
- W2110632922 creator A5056396619 @default.
- W2110632922 creator A5057959540 @default.
- W2110632922 creator A5061016096 @default.
- W2110632922 creator A5085804860 @default.
- W2110632922 date "2008-10-01" @default.
- W2110632922 modified "2023-10-16" @default.
- W2110632922 title "Fms-like Tyrosine Kinase (FLT) 3 and FLT3 Internal Tandem Duplication in Different Types of Adult Leukemia: Analysis of 147 Patients" @default.
- W2110632922 cites W133781217 @default.
- W2110632922 cites W148052780 @default.
- W2110632922 cites W1486112083 @default.
- W2110632922 cites W1506423591 @default.
- W2110632922 cites W170479056 @default.
- W2110632922 cites W1968306285 @default.
- W2110632922 cites W1971056717 @default.
- W2110632922 cites W1985349116 @default.
- W2110632922 cites W1991509879 @default.
- W2110632922 cites W2004477791 @default.
- W2110632922 cites W2018606122 @default.
- W2110632922 cites W2040454446 @default.
- W2110632922 cites W2040950977 @default.
- W2110632922 cites W2041027929 @default.
- W2110632922 cites W2049507332 @default.
- W2110632922 cites W2067954981 @default.
- W2110632922 cites W2071612423 @default.
- W2110632922 cites W2083975580 @default.
- W2110632922 cites W2095013649 @default.
- W2110632922 cites W2099524835 @default.
- W2110632922 cites W2125676392 @default.
- W2110632922 cites W2129615499 @default.
- W2110632922 cites W2130864403 @default.
- W2110632922 cites W2132912591 @default.
- W2110632922 cites W2150113701 @default.
- W2110632922 cites W2150470057 @default.
- W2110632922 cites W2153762797 @default.
- W2110632922 cites W2163515240 @default.
- W2110632922 cites W2321946412 @default.
- W2110632922 cites W2410122372 @default.
- W2110632922 doi "https://doi.org/10.3325/cmj.2008.5.650" @default.
- W2110632922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2582358" @default.
- W2110632922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18925699" @default.
- W2110632922 hasPublicationYear "2008" @default.
- W2110632922 type Work @default.
- W2110632922 sameAs 2110632922 @default.
- W2110632922 citedByCount "23" @default.
- W2110632922 countsByYear W21106329222012 @default.
- W2110632922 countsByYear W21106329222013 @default.
- W2110632922 countsByYear W21106329222014 @default.
- W2110632922 countsByYear W21106329222016 @default.
- W2110632922 countsByYear W21106329222017 @default.
- W2110632922 countsByYear W21106329222018 @default.
- W2110632922 countsByYear W21106329222019 @default.
- W2110632922 countsByYear W21106329222020 @default.
- W2110632922 countsByYear W21106329222021 @default.
- W2110632922 crossrefType "journal-article" @default.
- W2110632922 hasAuthorship W2110632922A5015269135 @default.
- W2110632922 hasAuthorship W2110632922A5022802322 @default.
- W2110632922 hasAuthorship W2110632922A5036131563 @default.
- W2110632922 hasAuthorship W2110632922A5042754123 @default.
- W2110632922 hasAuthorship W2110632922A5050440341 @default.
- W2110632922 hasAuthorship W2110632922A5052843372 @default.
- W2110632922 hasAuthorship W2110632922A5056396619 @default.
- W2110632922 hasAuthorship W2110632922A5057959540 @default.
- W2110632922 hasAuthorship W2110632922A5061016096 @default.
- W2110632922 hasAuthorship W2110632922A5085804860 @default.
- W2110632922 hasBestOaLocation W21106329221 @default.
- W2110632922 hasConcept C104317684 @default.
- W2110632922 hasConcept C126322002 @default.
- W2110632922 hasConcept C137061746 @default.
- W2110632922 hasConcept C170493617 @default.
- W2110632922 hasConcept C202751555 @default.
- W2110632922 hasConcept C203014093 @default.
- W2110632922 hasConcept C2776863199 @default.
- W2110632922 hasConcept C2776960273 @default.
- W2110632922 hasConcept C2778461978 @default.
- W2110632922 hasConcept C2778729363 @default.
- W2110632922 hasConcept C2779282312 @default.
- W2110632922 hasConcept C2780007613 @default.
- W2110632922 hasConcept C2910954276 @default.
- W2110632922 hasConcept C41650920 @default.
- W2110632922 hasConcept C42362537 @default.
- W2110632922 hasConcept C501734568 @default.
- W2110632922 hasConcept C502942594 @default.
- W2110632922 hasConcept C55493867 @default.
- W2110632922 hasConcept C71924100 @default.
- W2110632922 hasConcept C86803240 @default.
- W2110632922 hasConceptScore W2110632922C104317684 @default.
- W2110632922 hasConceptScore W2110632922C126322002 @default.
- W2110632922 hasConceptScore W2110632922C137061746 @default.
- W2110632922 hasConceptScore W2110632922C170493617 @default.
- W2110632922 hasConceptScore W2110632922C202751555 @default.